ARCHIVES

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

This article is from The Cancer Letter archive.

Vol. 34 No. 29 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCAB Commends Garb for His Contributions

December 11, 1981

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009